Simone Schüller1, Lukas Wisgrill1, Kambis Sadeghi1, Erich Gindl1, Hanns Helmer2, Peter Husslein2, Angelika Berger1, Andreas Spittler3, Elisabeth Förster-Waldl1. 1. Department of Paediatrics and Adolescent Medicine, Division of Neonatology, Paediatric Intensive Care & Neuropaediatrics, Medical University of Vienna, Vienna, Austria. 2. Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria. 3. Department of Surgery, Research Labs & Core Facility Flow Cytometry, Medical University of Vienna, Vienna, Austria.
Abstract
BACKGROUND: Preterm neonates display an impaired vaccine response. Neonatal antigen-presenting cells (APCs) are less effective to induce an adaptive immune response and to promote the development of immunological memory. Efficient adjuvantal toll-like receptor (TLR)-triggering may overcome the neonatal immunological impairment. Accordingly, the aim of this study was to investigate the immunostimulatory action of R-848 and CpG-B on neonatal APCs. METHODS: Surface marker and cytokine secretion of APCs were evaluated after incubation of cord blood and peripheral blood mononuclear cells with the indicated adjuvants and were analyzed using flow cytometry. RESULTS: TLR-specific stimulation resulted in a significant induction of costimulatory molecules on neonatal APCs. Stimulation with R-848 resulted in significant higher secretion of TNFα, IL-6, IL-10, IL-12/IL-23p40, IL-12p70, and IFN-γ. Interestingly, CpG-B resulted in significant higher secretion of TNFα and IL-6. CONCLUSION: In summary, the incubation of TLR-agonists induced activation and maturation of neonatal APCs. These data show that modern TLR-specific adjuvants achieve a direct effect and potent upregulation of activation and maturation markers and cytokines in preterm neonates. We thus conclude that agents triggering TLRs might possibly overcome neonatal lack of vaccine responses.
BACKGROUND: Preterm neonates display an impaired vaccine response. Neonatal antigen-presenting cells (APCs) are less effective to induce an adaptive immune response and to promote the development of immunological memory. Efficient adjuvantal toll-like receptor (TLR)-triggering may overcome the neonatal immunological impairment. Accordingly, the aim of this study was to investigate the immunostimulatory action of R-848 and CpG-B on neonatal APCs. METHODS: Surface marker and cytokine secretion of APCs were evaluated after incubation of cord blood and peripheral blood mononuclear cells with the indicated adjuvants and were analyzed using flow cytometry. RESULTS: TLR-specific stimulation resulted in a significant induction of costimulatory molecules on neonatal APCs. Stimulation with R-848 resulted in significant higher secretion of TNFα, IL-6, IL-10, IL-12/IL-23p40, IL-12p70, and IFN-γ. Interestingly, CpG-B resulted in significant higher secretion of TNFα and IL-6. CONCLUSION: In summary, the incubation of TLR-agonists induced activation and maturation of neonatal APCs. These data show that modern TLR-specific adjuvants achieve a direct effect and potent upregulation of activation and maturation markers and cytokines in preterm neonates. We thus conclude that agents triggering TLRs might possibly overcome neonatal lack of vaccine responses.
Authors: Carl T D'Angio; Roy J Heyne; Shahnaz Duara; Lucy C Holmes; T Michael O'Shea; Hongyue Wang; Dongwen Wang; Pablo J Sánchez; Robert C Welliver; Rita M Ryan; Kenneth C Schnabel; Caroline B Hall Journal: Pediatr Infect Dis J Date: 2011-07 Impact factor: 2.129
Authors: Elisabeth Förster-Waldl; Kambis Sadeghi; Dietmar Tamandl; Bernadette Gerhold; Ulrike Hallwirth; Klaudia Rohrmeister; Michael Hayde; Andrea R Prusa; Kurt Herkner; George Boltz-Nitulescu; Arnold Pollak; Andreas Spittler Journal: Pediatr Res Date: 2005-05-05 Impact factor: 3.756
Authors: Curtis L Cooper; Heather L Davis; Jonathan B Angel; Mary Lou Morris; Sue M Elfer; Isabelle Seguin; Arthur M Krieg; D William Cameron Journal: AIDS Date: 2005-09-23 Impact factor: 4.177
Authors: Issaka Sagara; Ruth D Ellis; Alassane Dicko; Mohamed B Niambele; Beh Kamate; Ousmane Guindo; Mahamadou S Sissoko; Michael P Fay; Merepen A Guindo; Ousmane Kante; Renion Saye; Kazutoyo Miura; Carole Long; Gregory E D Mullen; Mark Pierce; Laura B Martin; Kelly Rausch; Amagana Dolo; Dapa A Diallo; Louis H Miller; Ogobara K Doumbo Journal: Vaccine Date: 2009-10-27 Impact factor: 3.641
Authors: Xueyan Zhang; Fengbo Wu; Ke Men; Rong Huang; Bailin Zhou; Rui Zhang; Rui Zou; Li Yang Journal: Nanoscale Res Lett Date: 2018-08-17 Impact factor: 4.703
Authors: Sebastian Wirsching; Marina Machtakova; Frauke Borgans; Leah Pretsch; Michael Fichter; Maximiliano L Cacicedo; Héloïse Thérien-Aubin; Katharina Landfester; Stephan Gehring Journal: Front Pediatr Date: 2022-09-13 Impact factor: 3.569
Authors: Simone S Schüller; Boris W Kramer; Eduardo Villamor; Andreas Spittler; Angelika Berger; Ofer Levy Journal: Front Pediatr Date: 2018-07-19 Impact factor: 3.418